IL-1 receptor blockade restores autophagy and reduces inflammation in chronic granulomatous disease in mice and in humans.
about
The Role of Autophagy-Related Proteins in Candida albicans InfectionsRoles of Autophagy and Autophagy-Related Proteins in Antifungal ImmunityGenetic disorders coupled to ROS deficiencyThe cooperation between the autophagy machinery and the inflammasome to implement an appropriate innate immune response: do they regulate each other?Paving the way for predictive diagnostics and personalized treatment of invasive aspergillosisGenetics of inflammatory bowel disease from multifactorial to monogenic formsModulation of inflammation by autophagy: Consequences for human diseaseNeutrophils: Between host defence, immune modulation, and tissue injurySuccessful hepatectomy for hepatic abscess with chronic granulomatous disease: a case report.European contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS).Innate Lung Defense during Invasive Aspergillosis: New Mechanisms.Apoptotic neutrophils augment the inflammatory response to Mycobacterium tuberculosis infection in human macrophages.NOX2-dependent regulation of inflammationAutophagy protects C. elegans against necrosis during Pseudomonas aeruginosa infection.Applying Convergent Immunity to Innovative Vaccines Targeting Staphylococcus aureus.The complex roles of NADPH oxidases in fungal infection.Moderate hypoxia potentiates interleukin-1β production in activated human macrophages.Phagocyte NADPH oxidase, chronic granulomatous disease and mycobacterial infections.IL-1α signaling is critical for leukocyte recruitment after pulmonary Aspergillus fumigatus challenge.An expanding role for interleukin-1 blockade from gout to cancer.Small-molecule control of cytokine function: new opportunities for treating immune disordersTranscriptome analysis of cyclic AMP-dependent protein kinase A-regulated genes reveals the production of the novel natural compound fumipyrrole by Aspergillus fumigatus.The syndrome of hemophagocytic lymphohistiocytosis in primary immunodeficiencies: implications for differential diagnosis and pathogenesis.Extracellular Vesicles Derived from Bone Marrow Mesenchymal Stem Cells Protect against Experimental Colitis via Attenuating Colon Inflammation, Oxidative Stress and ApoptosisWhen the Fight against Fungi Goes WrongATG16L1 deficiency in macrophages drives clearance of uropathogenic E. coli in an IL-1β-dependent mannerMaintaining intestinal health: the genetics and immunology of very early onset inflammatory bowel disease.Commensal Bacteria-Induced Inflammasome Activation in Mouse and Human Macrophages Is Dependent on Potassium Efflux but Does Not Require Phagocytosis or Bacterial Viability.Molecular characterization of LC3-associated phagocytosis reveals distinct roles for Rubicon, NOX2 and autophagy proteinsToward an Inclusive, Congruent, and Precise Definition of Autoinflammatory DiseasesCommensal Bacteria-induced Interleukin 1β (IL-1β) Secreted by Macrophages Up-regulates Hepcidin Expression in Hepatocytes by Activating the Bone Morphogenetic Protein Signaling Pathway.NADPH oxidase controls neutrophilic response to sterile inflammation in mice by regulating the IL-1α/G-CSF axis.Detection of a microbial metabolite by STING regulates inflammasome activation in response to Chlamydia trachomatis infection.IL-1 receptor antagonist ameliorates inflammasome-dependent inflammation in murine and human cystic fibrosisThe DNA methylation profile of activated human natural killer cells.Intestinal Autophagy and Its Pharmacological Control in Inflammatory Bowel Disease.The role of interleukin-1 family members in the host defence against Aspergillus fumigatus.Role of inflammasomes in intestinal inflammation and Crohn's disease.The inflammasome and IL-1β: implications for the treatment of inflammatory diseases.The interplay between inflammasome activation and antifungal host defense.
P2860
Q26752567-B1E4FE8C-E2DE-4CBC-A23E-BDB996593363Q26765850-39EFD8F1-ACDE-4A66-B21A-9BD05F841150Q26799545-3A8F0373-C74A-4116-BE56-F174BBA62C58Q27026138-492C3F99-0DB6-4155-B1ED-EB8CAFDB918AQ28081259-4EE89641-7F5A-4D9D-B7AF-CF148B32EF79Q28081673-78A881AE-DB76-49E1-9624-D7F2446E1D23Q28082840-C5AB7907-D5D8-47FC-9749-C831401F84E6Q28087227-4B0FE151-7F08-4C5A-A4BB-E42989440CC2Q33606830-AD867694-3005-4FAE-9A87-932A9AB8C495Q33761211-9085632F-2A12-4552-8043-CF3E70CA8312Q33810700-2C28784F-83F2-421F-A318-9028112AAA86Q33855500-89DA6981-818F-44C9-AF1C-243734B83BD6Q33911333-D634075F-6E49-4BC2-854A-6EBCCA7AA0C8Q34119935-1471301E-D49A-4709-989A-FA3450B195C7Q34250054-2080E3B3-9E48-46C2-B6A3-8B25E48A7445Q34344590-43FA7C36-D343-4E83-903B-5275379E615BQ34403101-3697B15C-EBFC-44FA-8977-F4E8858B5FD8Q34423996-6D53915B-6966-47F0-9B37-DAA85D1C4214Q35023529-129EA174-5B32-4FD1-BFFC-F6FA135DEF9AQ35219001-589DEA95-23D7-4B2B-AAD9-5163A5732C6AQ35252669-A02F0E03-F1F7-42B6-9356-0A33CE4A1885Q35587757-5E345D56-A04F-4717-8B94-9888D10FB4A4Q35800864-42D62C8D-7D4C-476B-84BA-7AB6F4AAF460Q35808157-52CA4B3F-9BCD-446A-A25B-D2A3062764C0Q35914364-1E8DADEB-2804-42E7-B4FA-9219EFC0653CQ35941046-1EE61D65-207E-499F-83C6-86FDB0F0F05EQ36071413-93CE7E34-65CF-4219-8357-6427C9D4A23BQ36098791-22D6D49F-461C-44C8-AF46-E558E5115162Q36181466-7FEF2787-36A5-431E-9EB7-FD85E284E215Q36369784-529A43F7-01A0-455F-84B2-5AE8B71F1FB9Q36382005-AA3E0AF9-FE08-4061-8490-F82F373B6D72Q36382191-16ECB5C8-2123-4B7D-B408-7FE29E32EAFDQ36389473-F80FA699-981C-4586-8808-4B2821BAEBB1Q36690556-36D321B1-24EC-416D-89FC-792BEDC9C90BQ36956985-3AEF7751-E853-4389-889A-39D0B82D10ACQ37570542-D7CA852B-8E08-41EF-92D2-223E8DF1202DQ38232426-48FCBC39-FB62-495D-953A-0C2D28A06757Q38291767-3A5A6938-7084-48FD-B877-3A0E4B2AB34CQ38389302-0DE1AEA5-0A78-4B5B-A6D5-B0B7E6F5EE57Q38423391-2D7944B1-6CEB-411E-A0CA-1F4EB67AF19E
P2860
IL-1 receptor blockade restores autophagy and reduces inflammation in chronic granulomatous disease in mice and in humans.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 18 February 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
IL-1 receptor blockade restore ...... disease in mice and in humans.
@en
IL-1 receptor blockade restore ...... disease in mice and in humans.
@nl
type
label
IL-1 receptor blockade restore ...... disease in mice and in humans.
@en
IL-1 receptor blockade restore ...... disease in mice and in humans.
@nl
prefLabel
IL-1 receptor blockade restore ...... disease in mice and in humans.
@en
IL-1 receptor blockade restore ...... disease in mice and in humans.
@nl
P2093
P2860
P50
P356
P1476
IL-1 receptor blockade restore ...... disease in mice and in humans.
@en
P2093
Andrea Casagrande
Frank L van de Veerdonk
Georgios Chamilos
Jos W M van der Meer
Kara L Conway
Leo A B Joosten
Mihai G Netea
Ramnik J Xavier
Rossana Iannitti
Sanne P Smeekens
P2860
P304
P356
10.1073/PNAS.1322831111
P407
P577
2014-02-18T00:00:00Z